Potential Therapeutic Effect of Traditional Chinese Medicine on Coronavirus Disease 2019: A Review

被引:22
作者
Qiu, Qin [1 ]
Huang, Yuge [2 ]
Liu, Xiaohua [1 ]
Huang, Fangfang [1 ]
Li, Xiaoling [3 ]
Cui, Liao [4 ]
Luo, Hui [5 ]
Luo, Lianxiang [5 ,6 ]
机构
[1] Guangdong Med Univ, Grad Sch, Zhanjiang, Peoples R China
[2] Guangdong Med Univ, Dept Pediat, Affiliated Hosp, Zhanjiang, Peoples R China
[3] Guangdong Med Univ, Anim Expt Ctr, Zhanjiang, Peoples R China
[4] Guangdong Med Univ, Guangdong Key Lab Res & Dev Nat Drugs, Zhanjiang, Peoples R China
[5] Guangdong Med Univ, Marine Biomed Res Inst, Zhanjiang, Peoples R China
[6] Marine Biomed Res Inst Guangdong Zhanjiang, Zhanjiang, Peoples R China
关键词
SARS-CoV-2; COVID-19; traditional Chinese medicine; therapeutic effect; technology; NATURAL HERBAL MEDICINE; SARS-CORONAVIRUS; XUEBIJING INJECTION; LUNG INJURY; SARS-COV-2; COVID-19; MODEL; RUTIN; REPLICATION; FLAVONOIDS;
D O I
10.3389/fphar.2020.570893
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The Coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 has been rapidly spreading globally and has caused worldwide social and economic disruption. Currently, no specific antiviral drugs or clinically effective vaccines are available to prevent and treat COVID-19. Traditional Chinese medicine (TCM) can facilitate syndrome differentiation and treatment according to the clinical manifestations of patients and has demonstrated effectiveness in epidemic prevention and control. In China, TCM intervention has helped to control the epidemic; however, TCM has not been fully recognized worldwide. In this review, we summarize the epidemiology and etiological characteristics of severe acute respiratory syndrome coronavirus 2 and the prevention and treatment measures of COVID-19. Additionally, we describe the application of TCM in the treatment of COVID-19 and the identification of small molecules of TCM that demonstrate anti-coronavirus activity. We also analyze the current problems associated with the recognition of TCM. We hope that, through the contribution of TCM, combined with modern technological research and the support of our international counterparts, COVID-19 can be effectively controlled and treated.
引用
收藏
页数:16
相关论文
共 163 条
[41]   Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus [J].
Cinatl, J ;
Morgenstern, B ;
Bauer, G ;
Chandra, P ;
Rabenau, H ;
Doerr, HW .
LANCET, 2003, 361 (9374) :2045-2046
[42]   Fatal Eosinophilic Myocarditis in a Healthy 17-Year-Old Male with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2c) [J].
Craver, Randall ;
Huber, Samantha ;
Sandomirsky, Marrianna ;
McKenna, Dwight ;
Schieffelin, John ;
Finger, Leron .
FETAL AND PEDIATRIC PATHOLOGY, 2020, 39 (03) :263-268
[43]   A guideline for homology modeling of the proteins from newly discovered betacoronavirus, 2019 novel coronavirus (2019-nCoV) [J].
Dong, Shengjie ;
Sun, Jiachen ;
Mao, Zhuo ;
Wang, Lu ;
Lu, Yi-Lin ;
Li, Jiesen .
JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (09) :1542-1548
[44]   Natural herbal medicine Lianhuaqingwen capsule anti-influenza A (H1N1) trial: a randomized, double blind, positive controlled clinical trial [J].
Duan Zhong-ping ;
Jia Zhen-hua ;
Zhang Jian ;
Liu Shuang ;
Chen Yu ;
Liang Lian-chun ;
Zhang Chang-qing ;
Zhang Zong ;
Sun Yan ;
Zhang Shu-qin ;
Wang Yong-yan ;
Wu Yi-ling .
CHINESE MEDICAL JOURNAL, 2011, 124 (18) :2925-2933
[45]   Ultrastructural Evidence for Direct Renal Infection with SARS-CoV-2 [J].
Farkash, Evan A. ;
Wilson, Allecia M. ;
Jentzen, Jeffrey M. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2020, 31 (08) :1683-1687
[46]  
Fehr AR, 2015, METHODS MOL BIOL, V1282, P1, DOI 10.1007/978-1-4939-2438-7_1
[47]   COVID-19 and Liver Dysfunction: Current Insights and Emergent Therapeutic Strategies [J].
Feng, Gong ;
Zheng, Kenneth I. ;
Yan, Qin-Qin ;
Rios, Rafael S. ;
Targher, Giovanni ;
Byrne, Christopher D. ;
Van Poucke, Sven ;
Liu, Wen-Yue ;
Zheng, Ming-Hua .
JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2020, 8 (01) :18-24
[48]   RETRACTED: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial (Retracted article. See vol. 65, 2025) [J].
Gautret, Philippe ;
Lagier, Jean-Christophe ;
Parola, Philippe ;
Van Thuan Hoang ;
Meddeb, Line ;
Mailhe, Morgane ;
Doudier, Barbara ;
Courjon, Johan ;
Giordanengo, Valerie ;
Vieira, Vera Esteves ;
Dupont, Herve Tissot ;
Honore, Stephane ;
Colson, Philippe ;
Chabriere, Eric ;
La Scola, Bernard ;
Rolain, Jean-Marc ;
Brouqui, Philippe ;
Raoult, Didier .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 56 (01)
[49]   Similarities in Cutaneous Histopathological Patterns between COVID-19-positive and COVID-19 High-risk Patients with Skin Dermatosis [J].
Gianotti, Raffaele ;
Coggi, Antonella ;
Boggio, Francesca ;
Fellegara, Giovanni .
ACTA DERMATO-VENEREOLOGICA, 2020, 100 :1-5
[50]   Potential Role of Flavonoids in Treating Chronic Inflammatory Diseases with a Special Focus on the Anti-Inflammatory Activity of Apigenin [J].
Ginwala, Rashida ;
Bhavsar, Raina ;
Chigbu, De Gaulle I. ;
Jain, Pooja ;
Khan, Zafar K. .
ANTIOXIDANTS, 2019, 8 (02)